In summary, our results identified NLRP3 as an integral functional target of HDAC2 and substantiated the NLRP3 pathway, in which HDAC2 governs pharmacological pyroptosis in colorectal carcinoma by modulating NLRP3 levels. The gene discussed is HDAC2; the disease is colorectal carcinoma.